发明名称 Antibodies to matrix metalloproteinase 9
摘要 Disclosed is a method of detecting human MMP9 in a sample, comprising: a) contacting the sample with an antibody or antigen-binding fragment thereof comprising a heavy chain variable (VH) region and a light chain variable (VL), wherein the heavy chain variable region comprises a CDR1 comprising the amino acid sequence set forth in SEQ ID NO: 34, a CDR2 comprising the amino acid sequence set forth in SEQ ID NO: 35, and a CDR3 comprising the amino acid sequence set forth in SEQ ID NO: 36; wherein the light chain variable domain (VL) comprises a CDR1 comprising the amino acid sequence set forth in SEQ ID NO: 37, a CDR2 comprising the amino acid sequence set forth in SEQ ID NO: 38, and a CDR3 comprising the amino acid sequence set forth in SEQ ID NO: 39; and b) detecting binding of the antibody or antigen-binding fragment thereof to human MMP9 in the sample, thereby detecting the presence or absence of the human MMP9.
申请公布号 NZ629888(A) 申请公布日期 2017.02.24
申请号 NZ20120629888 申请日期 2012.02.29
申请人 GILEAD BIOLOGICS INC. 发明人 Mccauley Scott;Smith Victoria
分类号 C07K16/40;A61K39/395;C12N9/64 主分类号 C07K16/40
代理机构 代理人
主权项
地址